Archford Capital Strategies’s Avanos Medical AVNS Stock Holding History

Archford Capital Strategies’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-3	Closed	–	–	553
2019 Q1	$0	Hold	3	–	–	﹤0.01%	520
2018 Q4	$0	Hold	3	–	–	﹤0.01%	504
2018 Q3	$0	Buy	+3	New	+$193	﹤0.01%	538
2018 Q2	–	Sell	-32	Closed	-$1K	–	679
2018 Q1	$1K	Buy	+32	New	+$1.52K	﹤0.01%	548
2017 Q2	–	Sell	-519	Closed	-$19K	–	231
2017 Q1	$19K	Sell	519 -16	-3%	-$623	0.01%	374
2016 Q4	$19K	Sell	535 -5	-0.9%	-$179	0.01%	327
2016 Q3	$18K	Buy	540 +3	+0.6%	+$105	0.01%	334
2016 Q2	$17K	Buy	+537	New	+$16.4K	0.01%	342
2016 Q1	–	Sell	-528	Closed	-$24K	–	212
2015 Q4	$24K	Buy	528 +499	+1,721%	+$15.5K	0.01%	353
2015 Q3	$1K	Hold	29	–	–	﹤0.01%	616
2015 Q2	$1K	Sell	29 -9	-24%	-$404	﹤0.01%	578
2015 Q1	$1.87K	Sell	38 -400	-91%	-$18.5K	﹤0.01%	541
2014 Q4	$20K	Buy	+438	New	+$17.2K	0.01%	293

Other funds holding AVNS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $627M AUM 43.41% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Archford Capital Strategies's AVNS Position: Q2 2019 in Review

Archford Capital Strategies sold out of Avanos Medical (AVNS) in Q2 2019, closing a stake of 3 shares.

Archford Capital Strategies first reported a position in AVNS in Q4 2014 and held it in 13 quarters. The position peaked at $24K in Q4 2015. 317 funds tracked by Wall St. Rank hold AVNS as of Q2 2019.

Archford Capital Strategies reported no remaining Avanos Medical position as of Q2 2019 after selling out during the quarter.
Archford Capital Strategies sold 3 Avanos Medical shares in Q2 2019.
Archford Capital Strategies first reported a position in Avanos Medical in Q4 2014 and held it in 13 quarters.
Archford Capital Strategies's Avanos Medical position peaked at $24K in Q4 2015.
317 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2019.

Based on Archford Capital Strategies's 13F filing for Q2 2019, filed 18 Jul 2019.